Fabry's disease (Fabry syndrome, Fabry disease or Fabry-Anderson disease) is a rare metabolic disease in which a gene mutation leads to an enzyme defect. The result is a reduced breakdown of metabolic products and their increased storage in the cell. This damages the cell and dies. As a result, organs are damaged and, depending on the organ damage, a variety of symptoms can occur.
The cause of Fabry's disease is a missing enzyme, α-galactosidase A. This enzyme occurs within the cells in certain compartments, the lysosomes, where it is needed to break down glycosphingolipids. Glycosphingolipids are a group of sugary fats that are required for the structure of the cell.Due to a genetic defect, this enzyme is missing, which means that various metabolic products (above all globotraosylceramide) accumulate within the cells and damage them. As a result, the cell dies and organ damage and functional disorders occur. This type of disease is called lysosomal storage disease, as the metabolic products in the cell accumulate within the lysosomes.
$config[ads_text1] not found
You might also be interested in this topic: Storage diseases - what are they?
Fabry disease is inherited in an X-linked manner. Sons of sick fathers are healthy because they only get the Y chromosome from the father, whereas the daughters always get sick because they inherit the X chromosome. Because sick men only have one X chromosome with the defective gene, the disease is much more severe in them than in women. Women also have a second X chromosome that can partially compensate for the defect
An early diagnosis is very important for the treatment of Fabry disease, because the earlier the symptoms are treated, the slower the disease progresses. There are certain centers that specialize in treating the symptoms of Fabry disease and that those affected should turn to. Since Fabry's disease is a multi-organ disease, the treatment is carried out by a team of heart specialists, kidney specialists, kidney specialists and other specialists.
In addition to alleviating the symptoms, the therapeutic approach has for several years aimed primarily at replacing the missing enzyme with an artificially produced α-galactosidase. This enzyme replacement therapy causes the metabolic products to be broken down and not deposited in the organs, thereby improving the patient's symptoms. If treatment is started early, the organ systems can be prevented from being damaged and the patients can lead an almost normal life.
$config[ads_text2] not foundRead more on the topic: Genetic diseases
Fabry disease is a disease that affects several organ systems at the same time; this is known as a so-called multi-organ disease. The accompanying symptoms are correspondingly different. The most common are:
Pain in the hands and feet
burning pains in the tips of the body (acra): nose, chin, ears
Changes in the skin
Kidney damage
Heart and vascular diseases
Vision problems
Digestive tract discomfort
Many patients with Fabry disease experience symptoms in the eyes. Characteristically, the cornea is cloudy due to fine deposits, which, however, do not significantly impair vision. The deposits are cream-colored and spread in a vortex over the cornea. This clinical picture is called cornea verticillata. The lens of the eye can also be affected by the opacities; this is called Fabry cataracts. The ophthalmologist diagnoses the changes in the eyes through an examination with a slit lamp, with which the cornea and the lens can be viewed enlarged.
$config[ads_text3] not found
You can find out more about the topic here: Opacity of the cornea
Changes to the skin are typical symptoms of Fabry's disease. Often, dark red to dark purple spots appear, which are spread over the skin like small wart-shaped bumps. These are angiokeratomas, a benign skin tumor. The points can be up to several millimeters in size and appear anywhere on the body.
$config[ads_text2] not foundFabry disease often causes discomfort in the blood vessels, which can lead to circulatory disorders in the brain and, in the worst case, a stroke. The risk of a stroke before the age of 50 for patients with Fabry disease is significantly increased. As a result, a stroke, along with kidney failure, is one of the main causes of death in Fabry syndrome.
Read more on the topic: Stroke - What Are The Signs?
Fabry disease is often accompanied by muscle pain. These mainly affect the hands, feet and face (nose, chin, ears). In many cases, the burning pain cannot be relieved by conventional painkillers, so in severe cases the doctor will prescribe opiates. In addition, so-called paresthesias often occur, which are abnormal sensations such as numbness, tingling or pins and needles.
Fabry disease is a serious disease that causes severe damage to the kidneys, heart and brain at an early age. Due to the reduced enzyme activity, fats are deposited in the vessels and organs, as a result of which the organs are damaged more and more and finally lose their function completely. If the disease remains undetected or if no treatment is given, patients with Fabry disease often die prematurely from heart disease, chronic kidney failure or a stroke. If left untreated, those affected have a greatly reduced life expectancy, which is only around 40 to 50 years. If the disease is recognized early and suitable treatment in the form of enzyme replacement therapy is started immediately, the patients have an almost normal life expectancy that is not far below the average age.
$config[ads_text4] not found
The diagnosis of Fabry disease is not always easy, and patients often have a long journey of suffering before the symptoms can be traced back to the disease. It often takes several years for a doctor to make the correct diagnosis. If Fabry's disease is suspected, the doctor makes the diagnosis using a series of laboratory diagnostic tests for which a blood sample must be taken. After confirming the diagnosis, the doctor will usually refer the patient to specific clinics that specialize in the treatment of lysosomal storage diseases.
There are a number of molecular genetic tests that can confirm the diagnosis of Fabry disease. First of all, a simple enzyme test can clarify whether there is a defect in the α-galactosidase. In men, a positive test result (i.e. decreased activity of α-galactosidase) is usually sufficient to determine the disease. Sick women can still have normal activity of the α-galactosidase enzyme in the blood, so a genetic analysis is also carried out in such cases. The genetic analysis can show whether the woman has a disease-causing mutation in the α-galactosidase gene.
